Skip to content

Drug interactions

Gemfibrozil + Resmetirom

Severity: Major

Gemfibrozil and Resmetirom: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Gemfibrozil strongly inhibits CYP2C8, which metabolizes resmetirom, and can substantially increase resmetirom exposure. This raises the risk of dose-related adverse effects such as gastrointestinal effects and liver toxicity.

What this interaction means in plain words

Gemfibrozil and Resmetirom can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Gemfibrozil belongs to Cardiovascular; Resmetirom belongs to Gastrointestinal Tract.

Evidence level: High

Why it happens

CYP2C8 inhibition reduces resmetirom clearance, with possible OATP1B1 inhibition adding to the increase.

What to do

Avoid the combination and use another lipid-lowering agent if one is needed.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Gemfibrozil and Resmetirom, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Gemfibrozil with Resmetirom?

MediHelp rates the interaction as major. Gemfibrozil and Resmetirom can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Gemfibrozil strongly inhibits CYP2C8, which metabolizes resmetirom, and can substantially increase resmetirom exposure. This raises the risk of dose-related adverse effects such as gastrointestinal effects and liver toxicity.

How serious is the interaction between Gemfibrozil and Resmetirom?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination and use another lipid-lowering agent if one is needed.

What other medicines interact with Resmetirom?

MediHelp also lists interactions of Resmetirom with, for example, Atorvastatin, Clopidogrel, Pravastatin. The full list is on the Resmetirom page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in